Bristol-Myers Squibb is selling its diabetes business to AstraZeneca for up to $4.3 billion as part of an effort to focus more on specialty drugs, the company said Thursday.
Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for treating dental erosion.
Endo announced Thursday that regulatory waiting periods in the United States and Canada related to its plans to acquire a Montreal-based drug maker have been terminated.
About 40 million credit and debit card accounts of Target customers were compromised between late November and the middle of this month, the mass merchandise retailer said Thursday.
Rite Aid appears to be transitioning from a turnaround phase to one in which it's looking more toward future opportunities, company executives suggested in a conference call Thursday morning when announcing the chain's third quarter 2014 results.
Perrigo has finalized its acquisition of Elan Corp., Perrigo said Wednesday.
Three organizations will receive part of $1.3 million in funding that German drug maker Merck KGaA and the National Multiple Sclerosis Society are distributing for MS research.
Endo Health Solutions will acquire the maker of a patch used to treat migraines that received Food and Drug Administration approval at the beginning of this year.
Everett Labs has acquired Quinnova Pharmaceuticals from Amneal Enterprises, Everett said Monday.
Valeant Pharmaceuticals International will acquire Solta Medical for about $250 million, Valeant said Monday.